T1	Participants 126 186	Ninety-seven women with moderate to severe preeclampsia (PE)
T2	Participants 261 317	22 women with severe PE gave birth to neonates with VLBW
T3	Participants 357 452	Seven were allocated to labetalol treatment (Group A), eight to hydralazine treatment (Group B)
T4	Participants 457 550	seven women received both drugs due to poor blood pressure control with a single drug therapy
T5	Participants 1430 1471	VLBW infants when the hypertensive mother
T6	Participants 660 702	Gestational age was 29.9 weeks (25.4-32.5)
T7	Participants 715 737	28.6 weeks (26.6-33.4)
T8	Participants 753 775	27.3 weeks (26.7-31.1)
T9	Participants 854 895	13 of the 22 infants weighed below 1000 g
